Patrick Campbell

A new retrospective analysis suggests CABG may be more appropriate for CAD patients with severely reduced left ventricular ejection fraction.

Results of a new study dive deeper into the impact of preoperative metformin use in diabetics.

Results of an analysis of more than 20 randomized trials indicates women are at a greater risk of MACE and all-cause mortality than men following PCI.

A new study in JAMA Ophthalmology is comparing 3 different pointwise methods for detecting visual field progression in patients with open-angle glaucoma.

The American Thoracic Society has released a set of guidelines to help clinicians treating patients with COVID-19.

Discussing research related to TAVR with a cardiac surgeon from Brigham and Women's Hospital.

Patrick Campbell sat down  with Paul Stewart, MD, Executive Dean of the Faculty of Medicine and Health at University of Leeds and editor in chief of the Journal of Clinical Endocrinology & Metabolism to discuss why endocrinologists are expressing additional concern for their patients during the COVID-19 outbreak.

Discussing the impact of the ongoing outbreak on endocrinology practices and endocrinologists with the Executive Dean of the Faculty of Medicine and Health at University of Leeds.

Discussing takeaways from the late-breaking abstracts related to TAVR presented at ACC.20/WCC with a cardiac surgeon from Brigham and Women's Hospital.

Discussing an editorial in the Journal of Clinical Endocrinology & Metabolism with journal editor in chief Paul Stewart, MD.

New data from ENDO 2020 has uncovered a potential link between loss of meibomian glands and increased blood glucose levels.

Results of the 5-year Protocol T extension study are offering insight into the differences in real-world treatment and study protocol with anti-VEGF treatments.

A discussion on how the COVID-19 outbreak might impact burnout among cardiologists and other medical professionals.

Discussing a study examining rates of burnouts in cardiology with lead investigator Laxmi Mehta, MD, director of preventative cardiology and women’s cardiovascular health at Ohio State University.

Analysis indicated 31.7% of hospitalized patients had ocular manifestations and 50% of those with ocular symptoms had severe cases of COVID-19.

Study from ENDO 2020 assesses the effects of teprotumumab based on the age, gender, and smoking status of patients.

New data from ENDO 2020 suggests the presence of erectile dysfunction and sexual symptoms was linked to increased risk of death.

A new study presented at the American College of Cardiology’s Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC) has revealed a low birth weight could serve as an indicator for increased risk of cardiovascular disease in mothers.

A new study examining the impact of increased protein intake in older women has returned promising results showing a potential reduction in the risk of one of the most common cardiovascular conditions.

Discussing a REDUCE-IT substudy presented at ACC.20/WCC examining the impact of various EPA levels on outcomes seen in REDUCE-IT.

Results of the TICO study support use of ticagrelor monotherapy for patients with ACS requiring PCI with drug-eluting stents.

Results of a TWILIGHT subanalysis suggest ticagrelor monotherapy might cause less bleeding without increasing events in patients with requiring complex PCI.

A new subanalysis from the TWILIGHT trial found benefits of ticagrelor monotherapy remained consistent across both diabetics and nondiabetics.

Results of the CARAVAGGIO trial found oral apixaban was noninferior to subcutaneous dalteparin for preventing cancer-associated VTE without increasing a patient’s risk for major bleeding.

Results of the SPYRAL-HTN OFF MED indicate renal denervation could prove useful for lowering SBP in patients with untreated hypertension.

Marc Bonaca, MD, discusses the results of a subgroup analysis examining the impact of concomitant clopidogrel use in VOYAGER-PAD study.

Results of POPular TAVI indicate concomitant clopidogrel with oral anticoagulants increases risk of bleeding in patients requiring long-term anticoagulation after TAVI.

Discussing the impact of rivaroxaban 2.5 mg BID plus aspirin in diabetics versus nondiabetics from the COMPASS trial with Deepak Bhatt, MD.

Marc Bonaca, MD, discusses the results of the VOYAGER-PAD trial in a special edition ACC House Call with HCPLive.

Data presented at ACC.20/WCC is shedding light on the impact of genotype-guided antiplatelet therapy in patients undergoing PCI for ACS or CAD.